Q3 2019 Holdings
Filed 2019-11-14 | 167 holdings | $165.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $106.9M | 1,109,874 | 64.7% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $39.2M | 1,933,221 | 23.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $5.7M | 84,896 | 3.5% |
| Akebia Therapeutics Inc(AKBA) | COMM | 00972D105 | $4.8M | 1,227,191 | 2.9% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $2.4M | 210,992 | 1.5% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $2.1M | 1,911,573 | 1.2% |
| Align Technology Inc(ALGN) | COMM | 016255101 | $1.8M | 10,000 | 1.1% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $1.5M | 516,734 | 0.9% |
| Natera(NTRA) | COMM | 632307104 | $101.7K | 3,100,560 | 0.1% |
| Amarin | ADR | 023111206 | $79.0K | 5,208,305 | 0.0% |
| Nextcure, Inc | COMM | 65343E108 | $77.8K | 2,521,856 | 0.0% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $54.8K | 2,104,278 | 0.0% |
| Spark Therapeutics | COMM | 84652J103 | $46.7K | 481,270 | 0.0% |
| Principia Biopharma(PRNB) | COMM | 74257L108 | $40.0K | 1,417,258 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $39.6K | 4,749,623 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $34.9K | 1,961,039 | 0.0% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $28.2K | 1,729,352 | 0.0% |
| Health Care Select Sector SpdrPut | COMM | 81369Y950 | $27.0K | 300,000 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | COMM | 05070R104 | $26.2K | 933,640 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COMM | 110122108 | $24.3K | 478,349 | 0.0% |
| Allergan plc | COMM | G0177J108 | $22.6K | 134,433 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMM | 92532F100 | $20.6K | 121,690 | 0.0% |
| Amgen Inc(AMGN) | COMM | 031162100 | $17.9K | 92,300 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GB00BYWYV | $17.4K | 2,400,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COMM | 64125C109 | $17.3K | 191,679 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $16.4K | 2,266,666 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $16.1K | 408,262 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $15.5K | 194,014 | 0.0% |
| Pfizer Inc(PFE) | COMM | 717081103 | $14.8K | 410,607 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $11.9K | 148,669 | 0.0% |
| Reata Pharmaceuticals IncPut | COMM | 75615P953 | $11.9K | 148,600 | 0.0% |
| Iterum Therapeutics | COMM | G6333L101 | $10.0K | 1,726,514 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COMM | 40637H109 | $9.9K | 636,167 | 0.0% |
| TG Therapeutics Inc(TGTX) | COMM | 88322Q108 | $9.7K | 1,733,628 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $9.7K | 287,245 | 0.0% |
| Chiasma(CHMA) | COMM | 16706W102 | $8.1K | 1,630,221 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COMM | 803607100 | $8.0K | 106,414 | 0.0% |
| Kiniksa Pharmaceuticals, Ltd | COMM CL A | G5269C101 | $7.9K | 922,700 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $7.4K | 581,554 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COMM | 00900T107 | $7.3K | 346,770 | 0.0% |
| Entasis Therapeutics Holdings Inc. | COMM | 293614103 | $7.0K | 1,180,178 | 0.0% |
| Kadmon Holdings Inc(KDMN) | COMM | 48283N106 | $6.6K | 2,609,758 | 0.0% |
| Dermira Inc(DERMEUR) | COMM | 24983L104 | $6.3K | 990,168 | 0.0% |
| Beigene LtdCall | COMM | 07725L902 | $6.1K | 50,000 | 0.0% |
| MyoKardia Inc | COMM | 62857M105 | $5.9K | 113,926 | 0.0% |
| Fate Therapeutics Inc(FATE) | COMM | 31189P102 | $5.9K | 381,600 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COMM | 03152W109 | $5.8K | 722,974 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COMM | 253031108 | $4.9K | 342,755 | 0.0% |
| Zymeworks Inc | COMM | 98985W102 | $4.7K | 188,438 | 0.0% |
| XBiotech Inc(XBIT) | COMM | 98400H102 | $3.8K | 358,663 | 0.0% |